SCHEMBL7879511

SCHEMBL7879511

BC1CN(S(=O)(=O)c2ccc(C)cc2)CCC(C)C1=O

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.49
KDM4E B2RXH2 1/20 0.49
PKM P14618 3/20 0.49
EBP Q15125 1/20 0.48
DHCR7 Q9UBM7 1/20 0.48
POLB P06746 1/20 0.48
HTT P42858 1/20 0.48
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
TDP1 Q9NUW8 1/20 0.46
LMNA P02545 2/20 0.45
MCOLN3 Q8TDD5 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
GAA P10253 1/20 0.44
ACHE P22303 1/20 0.44
TSHR P16473 1/20 0.44
CYP2C19 P33261 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL505406 0.84 ALDH1A1 (0.49) ALDH1A1KDM4EPKMEBPDHCR7
SCHEMBL8185779 0.78 EBP (0.63) ALDH1A1KDM4EPKMEBPDHCR7
SCHEMBL6882681 0.78 EBP (0.63) ALDH1A1KDM4EPKMEBPDHCR7
SCHEMBL13818486 0.78 EBP (0.63) ALDH1A1KDM4EPKMEBPDHCR7
SCHEMBL29025668 0.77 PKM (0.54) ALDH1A1KDM4EPKMEBPDHCR7
SCHEMBL493725 0.76 PKM (0.61) ALDH1A1KDM4EPKMEBPDHCR7
SCHEMBL505404 0.76 ALDH1A1 (0.59) ALDH1A1KDM4EPKMEBPDHCR7
SCHEMBL4750626 0.75 PKM (0.59) ALDH1A1KDM4EPKMPOLBHTT
SCHEMBL4750625 0.75 PKM (0.59) ALDH1A1KDM4EPKMPOLBHTT
SCHEMBL266466 0.75 MEN1 (0.77) ALDH1A1KDM4EPKMEBPDHCR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010114971-A1 COMPOUNDS FOR TREATING DISORDERS MEDIATED BY METABOTROPIC GLUTAMATE RECEPTOR 5, AND METHODS OF USE THEREOF SEPRACOR INC. (US) 2010-10-07 WO disclosed